These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10853843)

  • 1. Sequential re-analysis of a phase-III clinical trial in non-small cell lung cancer.
    Donaldson N; Dillman RO; Wallace J; Ortiz-Hurtado A
    Eur Respir J; 2000 May; 15(5):821-7. PubMed ID: 10853843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
    Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
    J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer.
    George SL; Li C; Berry DA; Green MR
    Stat Med; 1994 Jul 15-30; 13(13-14):1313-27. PubMed ID: 7973212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer.
    Thatcher N; Faivre-Finn C; Blackhall F; Anderson H; Lorigan P
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5051s-5056s. PubMed ID: 16000613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing treatment and analysis of prognostic factors for locally advanced nonsmall cell lung cancer in resource-limited population.
    Agarwal JP; Hotwani C; Prabhash K; Munshi A; Misra S; Mathew A; Kalyani N; Noronha V; Laskar SG; Joshi A; Purandare N; Tandon S; Sharma V
    Indian J Cancer; 2016; 53(1):96-101. PubMed ID: 27146753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer.
    Liao Z; Komaki R; Stevens C; Kelly J; Fossella F; Lee JS; Allen P; Cox JD
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):558-65. PubMed ID: 12062597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
    Furuse K; Fukuoka M; Kawahara M; Nishikawa H; Takada Y; Kudoh S; Katagami N; Ariyoshi Y
    J Clin Oncol; 1999 Sep; 17(9):2692-9. PubMed ID: 10561343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy in non-small cell lung cancer.
    Rowell NP; O'rourke NP
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002140. PubMed ID: 15495029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
    Kawahara M
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seamlessly expanding a randomized phase II trial to phase III.
    Inoue LY; Thall PF; Berry DA
    Biometrics; 2002 Dec; 58(4):823-31. PubMed ID: 12495136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.
    Fournel P; Robinet G; Thomas P; Souquet PJ; Léna H; Vergnenégre A; Delhoume JY; Le Treut J; Silvani JA; Dansin E; Bozonnat MC; Daurés JP; Mornex F; Pérol M;
    J Clin Oncol; 2005 Sep; 23(25):5910-7. PubMed ID: 16087956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
    Paesmans M; Sculier JP; Libert P; Bureau G; Dabouis G; Thiriaux J; Michel J; Van Cutsem O; Sergysels R; Mommen P; Klastersky J
    Eur J Cancer; 1997 Dec; 33(14):2326-32. PubMed ID: 9616276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer.
    Vokes EE; Crawford J; Bogart J; Socinski MA; Clamon G; Green MR
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5045s-5050s. PubMed ID: 16000612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma.
    Pignon T; Ruggieri S; Boutin C; Gouvernet J; Irisson M; Juin P; Astoul P
    Cancer; 1999 May; 85(10):2144-50. PubMed ID: 10326692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.
    Komaki R; Scott C; Ettinger D; Lee JS; Fossella FV; Curran W; Evans RF; Rubin P; Byhardt RW
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):149-55. PubMed ID: 9212017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812).
    Atagi S; Kawahara M; Tamura T; Noda K; Watanabe K; Yokoyama A; Sugiura T; Senba H; Ishikura S; Ikeda H; Ishizuka N; Saijo N;
    Jpn J Clin Oncol; 2005 Apr; 35(4):195-201. PubMed ID: 15845568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy in non-small cell lung cancer.
    O'Rourke N; Roqué I Figuls M; Farré Bernadó N; Macbeth F
    Cochrane Database Syst Rev; 2010 Jun; (6):CD002140. PubMed ID: 20556756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.